Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Andreas Brunschweiger , Damian W. YoungPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: 1st ed. 2022 Volume: 40 Weight: 0.444kg ISBN: 9783031186318ISBN 10: 3031186311 Pages: 276 Publication Date: 26 November 2023 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsA History of Selection-Based High-Throughput Screening Technologies for Hit Identification.- Barcoding Strategies for the Synthesis of Genetically Encoded Chemical Libraries.- Advancements in DEL-Compatible Chemical Reactions.- Design Considerations in Constructing and Screening DNA-Encoded Libraries.- Cheminformatics Approaches Aiding the Design and Selection of DNA-Encoded Libraries.- Selection Strategies in DNA-Encoded Libraries.- From DEL Selections to Validated Hits to Clinical Leads.- A Perspective on 30 Years of DNA-Encoded Chemistry.ReviewsAuthor InformationAndreas Brunschweiger studied Pharmacy at the University of Kiel. He obtained his Ph.D. in Medicinal Chemistry at the University of Bonn. Following postdoctoral stays at the University of Bonn, and at ETH Zurich, he is currently heading a group at TU Dortmund University. His research interests include DNA-encoded library technology, library design, screening, methods for data analysis, and medicinal chemistry. Damian W. Young received a B.S. degree in chemistry (with ACS Certification) from Howard University. He then spent a year working as a process chemist on the anti-HIV drug Fuzeon at Trimeris Inc. before earning a Ph.D. in organic chemistry from North Carolina State University. Following this, he conducted a postdoctoral fellowship at Harvard University and the Broad Institute of MIT and Harvard. He became a Group Leader within the Chemical Biology Program at the Broad. Dr Young is currently the Associate Director for the Center for Drug Discoveryat Baylor College of Medicine and a faculty member within the Department of Pharmacology and Chemical Biology. His research is focused on the application of diversity-oriented synthesis to DNA encoded chemistry technology and fragment-based drug discovery. Tab Content 6Author Website:Countries AvailableAll regions |
||||
